Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease.
Cikrikcioglu MA, Karatoprak C, Cakirca M, Kiskac M, Zorlu M, Cetin G, Yildiz K, Erkoc R, Alay M, Erkal S, Erkal SN, Dogan S, Kazancioglu R.
Cikrikcioglu MA, et al. Among authors: karatoprak c.
Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2530-7.
Eur Rev Med Pharmacol Sci. 2013.
PMID: 24089235
Free article.